← back to search

Harald Seifert

Heinrich Heine University Düsseldorf · DE
🔎 Find collaborators in Molecular Medicine · Infectious Diseases →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Medicine · Infectious Diseases
Research interest
Research interests include Antibiotic Resistance in Bacteria, Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing, and Antibiotics Pharmacokinetics and Efficacy.
h-index
83
citations
32,115
works
412
NIH funding
primary concept
Medicine
email

Recent publications

Impact of enhanced infection control and antimicrobial stewardship on infections by Clostridioides difficile, vancomycin-resistant enterococci, and third-generation cephalosporin-resistant Enterobacterales: a stepped-wedge cluster intervention study
Clinical Microbiology and Infection 2025cited by 2position: middledoi
Clinical and Genomic Characterization of Recalcitrant Enterococcal Bacteremia: A Multicenter Prospective Cohort Study (VENOUS).
2025cited by 2position: contributordoi
Gram-negative bloodstream infections in six German university hospitals, 2016-2020: clinical and microbiological features.
2025cited by 2position: contributordoi
IS<i>Aba1</i>-mediated <i>bla</i><sub>ADC</sub> disruption restores third-generation cephalosporin susceptibility in a clinical <i>Acinetobacter baumannii</i> isolate.
2025cited by 1position: contributordoi
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial
The Lancet Infectious Diseases 2024cited by 76position: middledoi
The Value of Next-Generation Sequencing in Diagnosis and Therapy of Critically Ill Patients with Suspected Bloodstream Infections: A Retrospective Cohort Study.
2024cited by 12position: contributordoi
Occurrence and trends of Clostridioides difficile infections in hospitalized patients: a prospective multi-centre cohort study in six German university hospitals, 2016–2020
Journal of Hospital Infection 2024cited by 8position: middledoi
Genomic Surveillance Uncovers a 10-Year Persistence of an OXA-24/40 <i>Acinetobacter baumannii</i> Clone in a Tertiary Hospital in Northern Spain.
2024cited by 8position: contributordoi
Gram-negative bloodstream infections in six German university hospitals, 2016–2020: clinical and microbiological features
Infection 2024cited by 4position: middledoi
<i>In vitro</i> activity of ozenoxacin against <i>Staphylococcus aureus</i> and <i>Streptococcus pyogenes</i> clinical isolates recovered in a worldwide multicentre study (2020-2022).
2024cited by 2position: contributordoi
Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centres.
2024cited by 1position: contributordoi
Ceftobiprole for Treatment of Complicated <i>Staphylococcus aureus</i> Bacteremia
New England Journal of Medicine 2023cited by 95position: middledoi
A global view on carbapenem-resistant &lt;i&gt;Acinetobacter baumannii&lt;/i&gt;.
2023cited by 92position: contributordoi
Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa
Cell 2023cited by 53position: middledoi
Resolving colistin resistance and heteroresistance in Enterobacter species.
2023cited by 43position: contributordoi
Darobactins Exhibiting Superior Antibiotic Activity by Cryo-EM Structure Guided Biosynthetic Engineering.
2023cited by 36position: contributordoi
In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates.
2023cited by 16position: contributordoi
&lt;i&gt;Klebsiella pneumonia&lt;/i&gt; in Sudan: Multidrug Resistance, Polyclonal Dissemination, and Virulence.
2023cited by 11position: contributordoi
Next-Generation Sequencing in Critically Ill COVID-19 Patients with Suspected Bloodstream Infections: A Retrospective Cohort Study.
2023cited by 8position: contributordoi
First identification of multidrug-resistant <i>Acinetobacter bereziniae</i> isolates harboring <i>bla</i> <sub>NDM-1</sub> from hospitals in South China.
2023cited by 7position: contributordoi
Development of an immunochromatographic lateral flow assay to rapidly detect OXA-23-, OXA-40-, OXA-58- and NDM-mediated carbapenem resistance determinants in <i>Acinetobacter baumannii</i>.
2023cited by 5position: contributordoi
Carbapenem resistance in Acinetobacter pittii isolates mediated by metallo-β-lactamases.
2023cited by 5position: contributordoi
Association of ward-level antibiotic consumption with healthcare-associated <i>Clostridioides difficile</i> infections: an ecological study in five German university hospitals, 2017–2019
Journal of Antimicrobial Chemotherapy 2023cited by 4position: middledoi
Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017-2019.
2023cited by 3position: contributordoi
In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17.
2023cited by 1position: contributordoi
Surveillance and Genomic Analysis of Third-Generation Cephalosporin-Resistant and Carbapenem-Resistant Klebsiella pneumoniae Complex in Germany
Antibiotics 2022cited by 36position: middledoi
Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018).
2022cited by 35position: contributordoi
Incidence of an Intracellular Multiplication Niche among Acinetobacter baumannii Clinical Isolates
mSystems 2022cited by 30position: middledoi
MRSA surveillance programmes worldwide: moving towards a harmonised international approach
International Journal of Antimicrobial Agents 2022cited by 30position: middledoi
Incidence of an Intracellular Multiplication Niche among Acinetobacter baumannii Clinical Isolates.
2022cited by 28position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 28 papers (2022–2025)Paul G. Higgins · University Hospital Cologne19 papers (2022–2025)Winfried V. Kern · Internationale Akademie Berlin11 papers (2013–2025) · 8 papers (2012–2022)Kyriaki Xanthopoulou · University of Cologne7 papers (2022–2025)Evelina Tacconelli · University of Tübingen7 papers (2016–2025)Michael Behnke · American University of Paris7 papers (2020–2025)Jan Rupp · University Medical Center Utrecht7 papers (2022–2025)Sarah V Walker · University Hospital Cologne6 papers (2022–2025)Petra Gastmeier · Charité - Universitätsmedizin Berlin6 papers (2020–2025)Yehuda Carmeli · Tel Aviv University6 papers (2012–2021)Rafael Cantón · Madrid Institute for Advanced Studies6 papers (2012–2024)Axel Kola · German Center for Infection Research4 papers (2012–2023)Spyros Pournaras · National and Kapodistrian University of Athens4 papers (2019–2021)Carsten E. Seyfert · University of Basel4 papers (2022–2023)Thomas C. Marlovits · SpringerNature4 papers (2022–2023) · 4 papers (2022–2025)Esther Wohlfarth · Antiinfectives Intelligence4 papers (2022–2023)Rolf Müller · Bernhard Nocht Institute for Tropical Medicine4 papers (2022–2023)Fabian Panter · Helmholtz Institute for Pharmaceutical Research Saarland4 papers (2022–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Medicine · Infectious Diseases →